# CLLmodel
Cost-effectiveness model comparing VenO vs ClbO and VenO vs Ibr in treatment-naive CLL without del17p/tp53-mutation

To open the model, please download a TreeAge Pro Healthcare. Make sure to chose "Viewer Healthcare" in the Trial License Type dropdown menu. 

https://www.treeage.com/trial-download/

If password is requested, type CLL (capitalized)

For further questions, please contact matilde@nih-economics.dk
